KnowOpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
More in Artificial Intelligence
- Rapidly scaling online storage to serve over 1 billion ChatGPT users (Part II) OpenAI
- Southeast Asia’s digital economy to hit $368 billion Google AI
- Securing our frontier model training environment OpenAI
- Gemini 4 Argon: Built to solve your hardest problems Google AI
- OpenAI and Poland’s NASK partner to advance AI safety and security OpenAI